Dose Adaptation of Capecitabine Using Mobile Phone Toxicity Monitoring (DATACAP)

This study has been completed.
Sponsor:
Collaborators:
oxBRC
Vodafone UK Foundation
Centre of Statistics and Medicine (CSM, Oxford)
Oncology Clinical Trials Office (OCTO, Oxford)
Information provided by (Responsible Party):
University of Oxford
ClinicalTrials.gov Identifier:
NCT01053104
First received: January 3, 2010
Last updated: July 24, 2012
Last verified: July 2012
No Study Results Posted on ClinicalTrials.gov for this Study
  Study Status: This study has been completed.
  Study Completion Date: April 2011
  Primary Completion Date: December 2010 (Final data collection date for primary outcome measure)